BM8.STU BIOMARIN PHARM (BM8.SG)

Other Metals & Mining Stuttgart Exchange
- EUR
Market cap
-
P/E
163.6x
P/B
1.79x
ROE
4.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is BM8.STU undervalued?

Graham number

The Graham number of BIOMARIN PHARM (BM8.SG) cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BIOMARIN PHARM (BM8.SG) fundamental analysis

No fundamental analysis for BIOMARIN PHARM (BM8.SG) yet.

BIOMARIN PHARM (BM8.SG) stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BIOMARIN PHARM (BM8.SG)

There is no Profile data available for BM8.SG.

Full company profile